Biomedical Bonding presents at Redeye Innovative Orthopedic
![](https://mb.cision.com/Public/20572/3733973/9464fa588b26d95b_800x800ar.png)
On March 21, Evelina Mikaelson, CEO, presents the latest developments in the company at Redeye.
The presentation is live broadcasted and can be followed at https://www.redeye.se/events/869691/innovative-orthopedic-2 where the replay and the presentations will be available afterwards.
For more information, please contact:
Evelina Mikaelson, CEO
Phone: +46 (0)76 34 22 824
E-mail: evelina.mikaelson@biomedicalbonding.com
Homepage: www.biomedicalbonding.com
Biomedical Bonding AB is a platform based Swedish MedTech company that develops cutting-edge medical adhesive fixators and novel surgical methodologies with focus on the ever-growing market of hard tissue restorations. The technological platform, Bonevolent™, is market disruptive and stands for a paradigm shift in personalized surgical interventions. BMB´s vision is to become the dominant global provider of unique adhesive products suited for fracture fixation and dental restoration market. BMB´s Bonevolent™ products are easy-to-use by clinicians, will increase patient safety, save costs and resources for health care and society as a whole. BMB is a privately held company headquartered in Stockholm, Sweden.